BGI Genomics to Inject 149 Million Yuan in Equity Investment Fund

MT Newswires Live09-11

BGI Genomics (SHE:300676) invested 149 million yuan in an equity investment fund, according to a Tuesday disclosure on the Shenzhen Stock Exchange.

The fund, Shaoxing Meiyue Medical Industry Equity Investment Partnership (Limited Partnership), will raise a capital of 500 million yuan.

The Chinese genomics services provider will own 29.8% of the fund's capital.

The other partners, Keqiao Jinkai New Materials, will own 70% of the fund after injecting 350 million yuan, while Kemei Health Management (Shaoxing Keqiao) will own the remaining 0.2% after injecting 1 million yuan.

Price (RMB): Â¥34.76, Change: Â¥-0.030, Percent Change: -0.09%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466474845?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-11 16:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466474845","market":"nz","top_or_hot":-1,"title":"BGI Genomics to Inject 149 Million Yuan in Equity Investment Fund","media":"MT Newswires Live","content":"<html><body><p> BGI Genomics (SHE:300676) invested 149 million yuan in an equity investment fund, according to a Tuesday disclosure on the Shenzhen Stock Exchange.</p><p>The fund, Shaoxing Meiyue Medical Industry Equity Investment Partnership (Limited Partnership), will raise a capital of 500 million yuan.</p><p>The Chinese genomics services provider will own 29.8% of the fund's capital.</p><p>The other partners, Keqiao Jinkai New Materials, will own 70% of the fund after injecting 350 million yuan, while Kemei Health Management (Shaoxing Keqiao) will own the remaining 0.2% after injecting 1 million yuan.</p><p>Price (RMB): Â¥34.76, Change: Â¥-0.030, Percent Change: -0.09%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BGI Genomics to Inject 149 Million Yuan in Equity Investment Fund</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBGI Genomics to Inject 149 Million Yuan in Equity Investment Fund\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-11 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BGI Genomics (SHE:300676) invested 149 million yuan in an equity investment fund, according to a Tuesday disclosure on the Shenzhen Stock Exchange.The fund, Shaoxing Meiyue Medical Industry Equity ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0197","symbol_name":"中小创蓝筹","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466474845","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466474845","pubTimestamp":1726043106,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BGI Genomics  invested 149 million yuan in an equity investment fund, according to a Tuesday disclosure on the Shenzhen Stock Exchange.The fund, Shaoxing Meiyue Medical Industry Equity Investment Partnership , will raise a capital of 500 million yuan.The Chinese genomics services provider will own 29.8% of the fund's capital.The other partners, Keqiao Jinkai New Materials, will own 70% of the fund after injecting 350 million yuan, while Kemei Health Management  will own the remaining 0.2% after injecting 1 million yuan.Price : 34.76, Change: -0.030, Percent Change: -0.09%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300676":"华大基因","BK0197":"中小创蓝筹","BK0046":"生物疫苗","BK0042":"基因检测","BK4215":"住宅房地产投资信托","BGI":"Birks Group Inc.","BK0196":"行业龙头","BK4094":"服装零售","EQR":"资产住宅公司","BK4585":"ETF&股票定投概念","BK0221":"专业技术","BK4588":"碎股"},"translate_title":"华大基因将向股权投资基金注入1.49亿元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300676":0.9,"BGI":1,"EQR":1},"content_text":"BGI Genomics (SHE:300676) invested 149 million yuan in an equity investment fund, according to a Tuesday disclosure on the Shenzhen Stock Exchange.The fund, Shaoxing Meiyue Medical Industry Equity Investment Partnership (Limited Partnership), will raise a capital of 500 million yuan.The Chinese genomics services provider will own 29.8% of the fund's capital.The other partners, Keqiao Jinkai New Materials, will own 70% of the fund after injecting 350 million yuan, while Kemei Health Management (Shaoxing Keqiao) will own the remaining 0.2% after injecting 1 million yuan.Price (RMB): Â¥34.76, Change: Â¥-0.030, Percent Change: -0.09%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466474845"}